Follow Us

Follow us on Twitter  Follow us on LinkedIn
 

02 April 2013

IASB(国際会計基準審議会)のED(公開草案)「デリバティブの契約更改とヘッジ会計の継続(IAS(国際会計基準)第39号「金融商品:認識及び測定」及びIFRS(国際財務報告基準)第9号「金融商品」の修正案)」に対してESMA(欧州証券市場機構)がコメント


Default: Change to:


ESMA published its comment letter to the IASB on ED Novation of Derivatives and Continuation of Hedge Accounting: Proposed amendments to IAS 39 and IFRS 9. ESMA comments are aimed at improving the decision-usefulness of financial statements and the transparency and enforceability of lFRSs.


ESMA has considered the IASBs ED Novation of Derivatives and Continuation of Hedge Accounting: Proposed Amendments to IAS 39 and IFRS 9. ESMA supports the proposed amendments to IAS 39 and IFRS 9 so that the novation of a hedging instrument does not cause an entity to discontinue hedge accounting if a number of conditions are met. The discontinuation of a hedge relationship following the novation of a derivative contract resulting from it being cleared through a central counterparty without changing other major terms would not reflect the objective of the clearing requirement introduced by the EMIR or similar legislation in other jurisdictions and would not provide useful information to users of financial statements.

Nonetheless, ESMA is concerned that by limiting the continuation of hedge accounting to novation resulting from central clearing that is “required by laws or regulations", the amendment would not capture all novations of derivatives resulting from central clearing that are concluded with the aim to reduce counterparty risks and could dis-incentivise central clearing on a voluntary basis.

Therefore, ESMA would support the approach that all novations of derivative contracts resulting from clearing through a central counterparty without changing the other major terms of the contracts benefit from the proposed exception.

Comment letter



© ESMA


< Next Previous >
Key
 Hover over the blue highlighted text to view the acronym meaning
Hover over these icons for more information



Add new comment